Podcast thumbnail for HFA Cardio Talk

HFA Cardio Talk

Claim This Podcast

by European Society of Cardiology

4.3(7 reviews)
53 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇳🇱
39

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality49
Social0
YouTube0
Engagement71

Podcast Overview

The HFA Cardio Talk provides the opportunity to anyone interested in Heart Failure to receive updates in the field with very specific and diverse topics, go on a deeper subject of an HFA course and to listen to a discussion of key opinion leaders with junior HF specialists. Each month, a new episode lasting approximately 15 minutes and taking the form of a conversation between a member of the HFA Young community and an internationally renowned expert is released. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, ESC TV Today and much more. Check them out!

Language

🇺🇲

Publishing Since

1/27/2022

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

39

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality49
Social0
YouTube0
Engagement71
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
18 minutes
Performing excellently!
good
Show Notes Quality
3.0/5

Recommendations available

Unlock the full report to see detailed tips

poor
Publishing Consistency
Every 30 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

2 verified contact emails on file for HFA Cardio Talk

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Late-breaking clinical science from Heart Failure Congress 2026

June 1, 2026

Late-breaking clinical science from Heart Failure Congress 2026

<p>With <span lang="IT" xml:lang="IT">Novi Yanti Sari,</span> <span lang="IT" xml:lang="IT">Siloam Hospitals Group, Jakarta - Indonesia,</span> <span lang="IT" xml:lang="IT">Sotiria Liori,</span> <span lang="EN-US" xml:lang="EN-US">National & Kapodistrian University of Athens Medical School, Athens - Greece,</span> <span lang="EN-US" xml:lang="EN-US">Sarah Birkhoelzer, University Dorset Hospital, Bournemouth - UK, Joseph Selvanayagam, Flinders University, Adelaide - Australia, Sam Straw, University of Leeds, Leeds - UK, Ida Arentz Taraldsen, Copenhagen University Hospital, Copenhagen - Denmark, Fabian Kerwagen,  University Hospital of Wurzburg, Wurzburg - Germany, Dirk Van Veldhuisen and Kevin Damman, University Medical Centre Groningen, Groningen - The Netherlands.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">In this episode, we discuss the late-breaking clinical science presented at the Heart Failure Congress 2026 in Barcelona, Spain.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">First, Sarah Birkhoelzer interviews Joseph Selvanayagam, who presents the results of RESOLVE-HCM, a trial evaluating perhexiline for regression of left ventricular hypertrophy in symptomatic hypertrophic cardiomyopathy.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Next, Sam Straw interviews Ida Arentz Taraldsen, who highlights the key findings of REDOX-AHF, a trial comparing restrictive versus liberal oxygenation targets in patients with acute heart failure and pulmonary congestion.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Finally, Fabian Kerwagen interviews Dirk Van Veldhuisen and Kevin Damman, who discuss the DECISION trial and the accompanying meta-analysis. DECISION evaluated low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction, while the meta-analysis assessed the efficacy and safety of digitalis glycosides across contemporary heart failure trials.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.</span></p>

Episode thumbnail for Cardio-Oncology and Heart Failure

May 1, 2026

Cardio-Oncology and Heart Failure

<p>With <span lang="EN-US" xml:lang="EN-US">Novi Yanti Sari, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia and</span> <span lang="EN-US" xml:lang="EN-US">Michelle Bloom, NYU Langone Health, New York, USA.</span></p> <p><span lang="EN-US" xml:lang="EN-US">In this episode Novi Yanti Sari speaks with Michelle Bloom about the intersection between cardio-oncology and heart failure. As cancer survival continues to improve, cardiovascular complications especially heart failure related to cancer therapies are increasingly encountered in clinical practice. The discussion explores the burden of heart failure among cancer survivors, mechanisms of cancer therapy-related cardiotoxicity, strategies for early detection and monitoring, management, and the importance of multidisciplinary collaboration between cardiologists and oncologists.</span></p> <p>This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.</p>

Episode thumbnail for Valvular heart disease: a new chapter in heart failure management

April 1, 2026

Valvular heart disease: a new chapter in heart failure management

<p>With <span lang="EN-US" xml:lang="EN-US">Giulia Bruno, Hospital Limerick, Limerick - Ireland and Piotr Ponikowski, Wroclaw Medical University, Wroclaw - Poland.</span></p> <p class="m_7129028891507196966gmail-isselectedend"><span lang= "EN-US" xml:lang="EN-US">In this episode, Giulia Bruno is joined by Piotr Ponikowski to explore the complex interplay between valvular heart disease and heart failure. As our understanding of secondary mitral and tricuspid regurgitation evolves, new questions are emerging around prognosis, optimal timing of intervention, and the role of transcatheter therapies.</span></p> <p class="m_7129028891507196966gmail-isselectedend"><span lang= "EN-US" xml:lang="EN-US">Together, they discuss how to approach management in these patients, the importance of guideline-directed medical therapy, and whether treating the valve can truly improve outcomes. This conversation highlights the challenges, current evidence, and future directions shaping this rapidly evolving field.</span></p> <p class="m_7129028891507196966gmail-isselectedend"> <strong>Recommended readings:</strong></p> <ul type="disc"> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). </span><a href= "https://doi.org/10.1093/eurheartj/ehaf194" target="_blank" rel= "noopener" data-saferedirecturl= "https://www.google.com/url?q=https://doi.org/10.1093/eurheartj/ehaf194&source=gmail&ust=1774607398954000&usg=AOvVaw14zRE6Z3zhz9kOY97omA-y">https://doi.org/10.1093/<wbr />eurheartj/ehaf194</a></li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. </span><a href= "https://doi.org/10.1093/eurheartj/ehad195" target="_blank" rel= "noopener" data-saferedirecturl= "https://www.google.com/url?q=https://doi.org/10.1093/eurheartj/ehad195&source=gmail&ust=1774607398954000&usg=AOvVaw1jhw65ZSMdcAkw2_VU1p0M">https://doi.org/10.1093/<wbr />eurheartj/ehad195</a></li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. </span><a href= "https://doi.org/10.1093/eurheartj/ehab086" target="_blank" rel= "noopener" data-saferedirecturl= "https://www.google.com/url?q=https://doi.org/10.1093/eurheartj/ehab086&source=gmail&ust=1774607398954000&usg=AOvVaw18DpXdFi5nWwjFu4Tj3-Pg">https://doi.org/10.1093/<wbr />eurheartj/ehab086</a></li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Coats AJ et al. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the HFA, EACVI, EHRA, and EAPCI of the ESC. </span>European Heart Journal. 2021. <a href="https://doi.org/10.1093/eurheartj/ehab086" target="_blank" rel="noopener" data-saferedirecturl= "https://www.google.com/url?q=https://doi.org/10.1093/eurheartj/ehab086&source=gmail&ust=1774607398954000&usg=AOvVaw18DpXdFi5nWwjFu4Tj3-Pg">https://doi.org/10.1093/<wbr />eurheartj/ehab086</a></li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Stone GW et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. </span>NEJM. 2018 (COAPT). DOI: 10.1056/NEJMoa1806640</li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Stone GW et al. Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation. </span>NEJM. 2023. DOI: 10.1056/NEJMoa2300213</li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Sorajja P et al. Transcatheter Repair for Patients with Tricuspid Regurgitation. </span>NEJM. 2023 (TRILUMINATE Pivotal). DOI: 10.1056/NEJMoa2300525</li> <li class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Iliadis C et al. Acute heart failure and valvular heart disease: a scientific statement of the HFA, ACVC and EAPCI of the ESC. </span>European Journal of Heart Failure. 2023. <a href="https://doi.org/10.1002/ejhf.70043" target= "_blank" rel="noopener" data-saferedirecturl= "https://www.google.com/url?q=https://doi.org/10.1002/ejhf.70043&source=gmail&ust=1774607398954000&usg=AOvVaw0Yr9AgYVD1e8PjX5LEcFZR">https://doi.org/10.1002/ejhf.<wbr />70043</a></li> </ul> <p>This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.</p>

53 total episodes available

Recent guests on HFA Cardio Talk

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Kevin Damman

Guest

Joao Pedro Ferreira

Guest

Marat Fudim

Guest

Jose Luis Morales Rull

Guest

Deep-dive analytics for HFA Cardio Talk

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is HFA Cardio Talk?

The HFA Cardio Talk provides the opportunity to anyone interested in Heart Failure to receive updates in the field with very specific and diverse topics, go on a deeper subject of an HFA course and to listen to a discussion of key opinion leaders with junior HF specialists. Each month, a new episode lasting approximately 15 minutes and taking the form of a conversation between a member of the HFA Young community and an internationally renowned expert is released.

You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, ESC TV Today and much more. Check them out!

How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.